Amwell® to report fourth quarter and full year 2025 operating results
Amwell (NYSE: AMWL) will report fourth quarter and full year 2025 operating results after market close on Thursday, Feb. 12, 2026.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Amwell (NYSE: AMWL) will report fourth quarter and full year 2025 operating results after market close on Thursday, Feb. 12, 2026. Management will host a live conference call and webcast at 5:00 p.m. ET to review results and provide a business update.
The full earnings release and live audio webcast will be available in the company's Investors section; a webcast replay will remain available at investors.amwell.com for approximately 90 days.
Details
News Market Reaction – AMWL
On Feb 6, the first trading day after this news, AMWL closed 4.47% above the previous close.
Data tracked by StockTitan Argus for the Feb 6 session.
Key Figures
- Earnings report date
- Feb. 12
- Q4 and full year 2025 operating results release after market close
- Conference call time
- 5 p.m. ET
- Start time for Q4 and full year 2025 earnings call
- Webcast replay duration
- 90 days
- Replay availability on investors.amwell.com
- Current share price
- $4.40
- Price before Q4/full-year 2025 earnings date announcement
Historical Context
-
Reported Q3 2025 financial results and hosted earnings call webcast.
-
Announced Q3 2025 earnings release timing and upcoming investor conferences.
-
Granted 76,198 RSUs to new employees under inducement plan.
-
Announced Q2 2025 financial results and scheduled related earnings call.
-
Extended Digital First contract supporting Military Health System digital care.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Key Terms
saas-based technical
webcast technical
AI-generated analysis. How Rhea-AI works. Not financial advice.
BOSTON, Feb. 05, 2026 (GLOBE NEWSWIRE) -- Amwell® (NYSE: AMWL), a leading provider of a comprehensive SaaS-based software platform for technology-enabled healthcare, will report fourth quarter and full year 2025 operating results after stock market trading hours on Thursday, Feb. 12.
Following the distribution of the earnings alert via wire services, the Amwell management team will host a live conference call and webcast at 5 p.m. ET to review the company's operating results and provide a general business update.
The full earnings report and the live audio webcast can be accessed by visiting the Investors section of the company's website. A webcast replay of the call will be available at investors.amwell.com for approximately 90 days.
About Amwell
Amwell offers payers and health systems a single, comprehensive, technology-enabled care platform. We use technology to provide patients with better access to more convenient, affordable and effective care. The Amwell platform includes software and services that power many clinical programs from Amwell and our growing number of partners. Our platform allows patients to experience unified, personalized and simple access to diversified clinical programs across the care continuum. As more people seek care online and more clinical programs become available, we offer integrated, future-ready, consistent solutions. The Amwell platform is proven, operating at a large scale, enabling care for millions of patients and their sponsors while delivering dependable outcomes. For almost two decades, Amwell has proudly served some of the largest and most sophisticated healthcare organizations in the U.S. and worldwide. For more information, visit business.amwell.com or LinkedIn.
Investors:
Asher Dewhurst
Media:
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.